0000899243-22-025702.txt : 20220707 0000899243-22-025702.hdr.sgml : 20220707 20220707162359 ACCESSION NUMBER: 0000899243-22-025702 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drazba Brian G. CENTRAL INDEX KEY: 0001507369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 221071892 MAIL ADDRESS: STREET 1: 18 NUTCRACKER LANE CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-05 0 0001262104 MEI Pharma, Inc. MEIP 0001507369 Drazba Brian G. C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 0.54 2022-07-05 4 A 0 350000 0.00 A 2032-07-05 Common Stock 350000 350000 D Stock Option (Right to Buy) 2.95 2031-07-01 Common Stock 200000 200000 D Stock Option (Right to Buy) 1.59 2027-04-03 Common Stock 150000 150000 D Stock Option (Right to Buy) 2.83 2027-07-06 Common Stock 50000 50000 D Stock Option (Right to Buy) 4.33 2028-06-22 Common Stock 130000 130000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 100000 100000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 230000 230000 D Stock Option (Right to Buy) 3.49 2030-07-02 Common Stock 230000 230000 D One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023. One-quarter of such options vested on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022. All of such options are presently exercisable. One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. /s/ Brian G. Drazba 2022-07-07